Cipla launches drug to treat H1N1 virus
ET NOW
2012-03-22
Views 13
Drug maker Cipla Ltd on Wednesday launched its generic version of Roche's Tamiflu, used in the treatment of the H1N1 swine flu virus, the firm said in a statement. Cipla's Oseltamivir brand, called Antiflu, will cost 475 rupees for 10 capsules, with 75 ml syrup will be similarly priced.
Report form
RELATED VIDEOS
